Chemed Corp (CHE)
416.57
-48.12 (-10.36%)
NYSE · Last Trade: Jul 30th, 7:46 PM EDT
Detailed Quote
Previous Close | 464.69 |
---|---|
Open | 419.56 |
Bid | 400.00 |
Ask | 431.76 |
Day's Range | 410.00 - 433.81 |
52 Week Range | 410.00 - 623.60 |
Volume | 522,014 |
Market Cap | 6.09B |
PE Ratio (TTM) | 20.30 |
EPS (TTM) | 20.5 |
Dividend & Yield | 2.000 (0.48%) |
1 Month Average Volume | 196,257 |
Chart
About Chemed Corp (CHE)
Chemed Inc is a publicly traded company that operates primarily in the healthcare sector, focusing on providing hospice and palliative care services through its subsidiary, VITAS Healthcare. The company is dedicated to improving the quality of life for patients facing terminal illnesses by delivering compassionate care and support to both patients and their families. Additionally, Chemed offers a range of plumbing and drain cleaning services through its Roto-Rooter brand, catering to residential and commercial customers. With a commitment to high standards of service and care, Chemed Inc plays a significant role in the healthcare and home services industries. Read More
News & Press Releases
MIRAMAR, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- VITAS Healthcare, one of the nation’s leading providers of hospice and palliative care, and a subsidiary of Chemed Corporation (NYSE: CHE), today announced that Nicholas M. Westfall will step down as chairman and chief executive officer to pursue other personal and professional opportunities. Joel L. Wherley, president and chief operating officer, was appointed by the Board to succeed Westfall as chief executive officer of VITAS Healthcare.
By VITAS Healthcare · Via GlobeNewswire · July 30, 2025
Chemed missed expectations on both the top and bottom lines with its second-quarter earnings.
Via The Motley Fool · July 30, 2025
Shares of healthcare services company Chemed Corporation (NYSE:CHE)
fell 9% in the afternoon session after the company reported disappointing second-quarter results which missed analysts' EPS and EBITDA estimates. Net income saw a steep 25.9% decline from the prior year's quarter. Chemed pointed to the impact of Medicare Cap billing limitations on its VITAS hospice business as a primary reason for the shortfall. Adding to the concerns, the company also announced the departure of a key executive, the CEO of the VITAS segment.
Via StockStory · July 30, 2025
Healthcare services company Chemed Corporation (NYSE:CHE) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.8% year on year to $618.8 million. Its non-GAAP profit of $4.27 per share was 14.3% below analysts’ consensus estimates.
Via StockStory · July 29, 2025
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2025, versus the comparable prior-year period.
By Chemed Corporation · Via Business Wire · July 29, 2025
Healthcare services company Chemed Corporation (NYSE:CHE)
will be reporting results this Tuesday after market hours. Here’s what to expect.
Via StockStory · July 27, 2025
Via Benzinga · July 25, 2025
Via Benzinga · July 15, 2025
The past year hasn't been kind to the stocks featured in this article.
Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.
Via StockStory · July 14, 2025
Via Benzinga · July 9, 2025
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Via StockStory · July 4, 2025
Shares of healthcare services company Chemed Corporation (NYSE:CHE)
fell 14.7% in the afternoon session after the company provided a negative update on its full-year 2025 guidance, citing issues with its VITAS hospice business.
Via StockStory · June 30, 2025
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange.
By Chemed Corporation · Via Business Wire · June 27, 2025
Via Benzinga · June 17, 2025
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via StockStory · June 13, 2025
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the senior health, home health & hospice industry, including Chemed (NYSE:CHE) and its peers.
Via StockStory · June 8, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 12.3%. This performance was noticeably worse than the S&P 500’s 1.9% fall.
Via StockStory · June 4, 2025